The Apollo Onyx Delivery Microcatheter (AOMC) is a DMSO-compatible, single-lumen, end hole cathet...
FDA Device Recall #Z-1252-2024 — Class II — January 11, 2024
Recall Summary
| Recall Number | Z-1252-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 11, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Micro Therapeutics, Inc. |
| Location | Irvine, CA |
| Product Type | Devices |
| Quantity | 82 units |
Product Description
The Apollo Onyx Delivery Microcatheter (AOMC) is a DMSO-compatible, single-lumen, end hole catheter designed for the infusion of the Onyx liquid embolic system (LES). The catheter has a semi-rigid proximal shaft and a highly flexible distal shaft to facilitate the advancement of the catheter in the anatomy. The proximal end of the catheter incorporates a standard Luer adapter to facilitate the attachment of accessories. The outer diameter surface of the catheter is hydrophilically coated to increase lubricity. The AOMC is designed to facilitate catheter retrieval in the event the catheter becomes entrapped within the vasculature. The distal section of the catheter incorporates a detachment zone that allows detachment of the distal tip when the force required to extract the catheter exceeds the force to detach the tip. The catheter has two radiopaque marker bands to visualize the position of the catheter and the detach zone area, one proximal to the detach zone and one at the distal end of the catheter.
Reason for Recall
European version of microcatheter were distributed within US which contain a different "Indications for Use".
Distribution Pattern
US Nationwide distribution in the states of AL, AZ, CA, CT, FL, GA, HI, IA, IL, IN, KS, MA, MD, MI, MO, NC, ND, NE, NV, NY, OH, OK, PA, SC, TN, TX, UT, VA, WA, WI.
Lot / Code Information
UDI: 00763000311438/ Lot # B510757, B593510, B610689
Other Recalls from Micro Therapeutics, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1246-2025 | Class I | Medtronic Pipeline Vantage Embolization Device ... | Jan 30, 2025 |
| Z-1245-2025 | Class I | Medtronic Pipeline Vantage Embolization Device ... | Jan 30, 2025 |
| Z-1253-2024 | Class II | The Apollo Onyx Delivery Microcatheter (AOMC) i... | Jan 11, 2024 |
| Z-1556-2022 | Class II | Echelon -14, 45 Tip Shape, REF 145-5092150, ste... | Jun 30, 2022 |
| Z-1557-2022 | Class II | Echelon -14 Micro Catheter, REF: 105-5092-150, ... | Jun 30, 2022 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.